OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
12 sep 2010 - 22:23
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus wins expansion of drug delivery evaluation contract with top-5 pharmaceutical company
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), the drug delivery company, announces today that it has won an expansion of a drug delivery technology evaluation contract with an existing client, a top-5 global pharmaceutical company. OctoPlus has performed feasibility work for multiple compounds of this client and the client has now decided to proceed with the evaluation of OctoPlus’ PolyActive® technology for an additional product candidate in its pipeline.
Datum laatste update: 01 september 2024